Bitcoin miner Marathon plans to make purchase to offset costs rewards ‘Halving’. Bitcoin ETFs are ”going to pass gold ETFs”, which hold nearly $100 billion in assets, a Bloomberg analyst predicts, and the first U.S. offshore wind farm is officially opened. Jane King with the latest from the Nasdaq.
Bitcoin retreat, Sustainable coffee pods, Not Satoshi
Bitcoin falls after monster rally. Keurig’s new coffee pods are plastic free & sustainable and U.K. high court says Australian Craig Wright is not Satoshi Nakamoto. Jane King with the latest from the Nasdaq.
Coinbase global, Hamas probe, Crypto miners, Methane emissions
Coinbase plans to offer $1 billion in convertible notes. U.S. probing the use of cryptocurrency before Israel attack by Hamas. Crypto miners pulling in more money than ever and global methane emissions near record high in 2023. Jane King with the latest from the Nasdaq
Jamie Dimon bitcoin, ESG Questions, Blockchain test
Chase CEO Jamie Dimon still does not like bitcoin but defends the right for people to own it. Academics question ESG studies that support investment and Goldman, BNY Mellon & others test blockchain network for capital markets. Jane King with the latest from the Nasdaq.
Diamond Lake Minerals takes a 24% stake in Avrio
Diamond Lake Minerals (OTCMKS: DLMI) takes a 24% stake in Avrio to secure its registered digital financial market infrastructure for the tokenization of digital assets.
Cardiol Therapeutics Inc. – Dedicated to healing the heart with innovative science
David Elsley, the President & CEO of Cardiol Therapeutics Inc. (Nasdaq: CRDL | TSX: CRDL), a company dedicated to healing the heart with innovative science, joins Vince Molinari to discuss their recent milestones to kick off 2024. Mr. Elsley shares the significance of Cardiol receiving the US FDA grant for Orphan Drug Designation for the company’s lead drug candidate, CardiolRx™, aimed at treating pericarditis, including recurrent pericarditis. He speaks to the severity of recurrent pericarditis, characterized by symptoms that significantly impact patients’ quality of life and physical activity. The FDA’s decision to grant ODD underscores the potential of CardiolRx™ to improve the lives of individuals suffering from this condition. They discuss Cardiol’s two ongoing Phase II clinical trials targeting rare diseases of recurrent pericarditis and acute myocarditis. Additionally, Mr. Elsley shares the market opportunity for the company’s potential treatment for heart failure – a leading cause of death and hospitalization in the developed world, with associated healthcare costs in the United States exceeding $30 billion annually.
Understanding ‘real world assets’ on the blockchain
Todd McDonald, Co-Founder and Chief Strategy Officer at R3, joins Remy Blaire to discuss understanding tokenization and real-world assets on the blockchain.
AtlasClear Holdings inc. – Aiming to create a more efficient platform for trading, and banking
John Schaible, Chief Strategy Officer at AtlasClear Holdings, inc., joins Vince Molinari to discuss ringing the opening bell and the future of the company. Atlas Clear aims to create a more efficient platform for trading, and banking.
Risks Bitcoin investors should be aware of
James Butterfill, Head of Research of CoinShares, joins Remy Blaire to discuss the Bitcoin price surge and the risks Bitcoin investors should be aware of.
Turning the smartphone into the earnphone
Dan Novaes, Chief Executive Officer at Mode Mobile, joins Vince Molinari to discuss how Mode Mobile created a state-of-the-art smartphone device with built-in earning features.